NRSN — NEUROSENSE THERAPEUTICS LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 13 SEC-registered investment managers reported holding NRSN (NEUROSENSE THERAPEUTICS LTD) in their latest 13F filings, with a combined reported value of $297.18K across 413.48K shares. That is +40.9% by share count (+109.03K shares) versus the previous quarter, while reported value moved +34.4%. Ownership is concentrated: the five largest holders account for 80.1% of reported value and the top ten for 97.3%.
Compared with the prior quarter, 3 opened new positions, 2 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of NEUROSENSE THERAPEUTICS LTD (NRSN) include ARMISTICE CAPITAL, LLC, Citadel Advisors, Citigroup Inc, ranked by reported 13F value among the 40 institutional holders on this page.
NRSN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 5 | 2.69K | $11.89K | -97.9% |
| Q2 2026 | 13 | 413.48K | $297.18K | +40.9% |
| Q1 2026 | 13 | 379.71K | $286.65K | -4.1% |
| Q4 2025 | 13 | 346.13K | $266.18K | -13.8% |
| Q3 2025 | 10 | 277.93K | $346.80K | +14.3% |
| Q2 2025 | 17 | 510.04K | $964.36K | +25.5% |
| Q1 2025 | 11 | 194.89K | $180.78K | -24.5% |
| Q4 2024 | 13 | 646.51K | $775.85K | +153.0% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+153.0%).
Top Institutional Holders (Q3 2026) — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.06K | $4.69K | 0.00% | Reduce | |
| 985 | $4.36K | 0.00% | Reduce | |
| 640 | $2.83K | 0.00% | Add | |
| 1 | $5 | 0.00% | New | |
| 1 | $4 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 108.64K | $78.22K | 0.00% | Add | |
| 100.00K | $72.00K | 0.00% | Add | |
| 78.00K | $56.16K | 0.07% | Hold | |
| 22.77K | $16.40K | 0.00% | Hold | |
| 21.15K | $15.23K | 0.00% | Hold | |
| 16.53K | $11.90K | 0.00% | Hold | |
| 15.87K | $11.43K | 0.00% | New | |
| 15.87K | $11.43K | 0.00% | Hold | |
| 11.47K | $8.26K | 0.00% | New | |
| 11.41K | $8.21K | 0.00% | Reduce | |
| 10.52K | $7.00K | 0.00% | New | |
| 1.00K | $757 | 0.00% | Hold | |
| 255 | $184 | 0.00% | Reduce |
Q1 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 78.00K | $58.89K | 0.04% | Reduce | |
| 50.00K | $37.75K | 0.00% | New | |
| 49.10K | $37.07K | 0.00% | Add | |
| 44.45K | $33.56K | 0.00% | Reduce | |
| 40.00K | $30.20K | 0.00% | Hold | |
| 28.67K | $21.65K | 0.00% | New | |
| 22.77K | $17.19K | 0.00% | Hold | |
| 21.15K | $15.97K | 0.00% | New | |
| 16.53K | $12.48K | 0.00% | Hold | |
| 15.87K | $11.98K | 0.00% | Hold | |
| 11.91K | $8.99K | 0.00% | Hold | |
| 1.00K | $731 | 0.00% | Hold | |
| 265 | $200 | 0.00% | Reduce |
Q4 2025 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $76.90K | 0.05% | New | |
| 51.55K | $39.64K | 0.00% | Add | |
| 40.00K | $30.76K | 0.00% | Hold | |
| 35.75K | $27.49K | 0.00% | New | |
| 30.87K | $23.74K | 0.00% | Add | |
| 22.77K | $17.52K | 0.00% | Add | |
| 17.93K | $13.79K | 0.00% | Reduce | |
| 16.53K | $12.71K | 0.00% | New | |
| 15.87K | $12.20K | 0.00% | Hold | |
| 11.91K | $9.16K | 0.00% | New | |
| 1.46K | $1.12K | 0.00% | Hold | |
| 1.00K | $769 | 0.00% | Hold | |
| 500 | $385 | 0.00% | New |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 95.38K | $119.22K | 0.00% | Add | |
| 66.40K | $83.00K | 0.00% | Reduce | |
| 40.00K | $50.00K | 0.00% | Hold | |
| 21.09K | $26.36K | 0.00% | New | |
| 21.08K | $26.00K | 0.00% | Hold | |
| 15.87K | $19.84K | 0.00% | Hold | |
| 14.66K | $18.32K | 0.00% | Add | |
| 1.46K | $1.82K | 0.00% | Reduce | |
| 1.00K | $1.24K | 0.00% | Reduce | |
| 1.00K | $1.00K | 0.00% | Hold |
Q2 2025 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 149.24K | $282.07K | 0.00% | New | |
| 79.90K | $151.01K | 0.00% | Add | |
| 60.00K | $113.40K | 0.07% | New | |
| 49.92K | $94.36K | 0.00% | New | |
| 40.00K | $75.60K | 0.00% | Hold | |
| 28.69K | $54.22K | 0.00% | New | |
| 21.69K | $41.00K | 0.00% | New | |
| 21.08K | $40.00K | 0.00% | Add | |
| 15.87K | $29.99K | 0.00% | Hold | |
| 11.83K | $22.36K | 0.00% | New | |
| 10.92K | $20.75K | 0.00% | New | |
| 6.80K | $12.85K | 0.00% | New | |
| 6.53K | $12.34K | 0.01% | Reduce | |
| 4.46K | $8.42K | 0.00% | Add | |
| 1.61K | $3.04K | 0.00% | Reduce | |
| 1.00K | $2.00K | 0.00% | Hold | |
| 500 | $945 | 0.00% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 15.87K sh · $11.43K
- XTX Topco Ltd 11.47K sh · $8.26K
- HRT FINANCIAL LP 10.52K sh · $7.00K
Fully Exited (vs previous quarter)
- Two Sigma Investments sold 44.45K sh · $33.56K
- MEITAV INVESTMENT HOUSE LTD sold 40.00K sh · $30.20K
- JANE STREET GROUP, LLC sold 28.67K sh · $21.65K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PNC Financial Services | 1.06K | 21.15K | 21.15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 985 | 108.64K | 49.10K | 30.87K | 14.66K | 1.61K | 2.27K | — | — | — | 11.93K | 5.50K | 9.66K | — | 4.76K | 4.07K | 1.83K | 13.43K | 1.88K | 8.02K |
| SBI Securities Co., Ltd. | 640 | 255 | 265 | 1.46K | 1.46K | 4.46K | 175 | 175 | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1 | — | — | — | — | — | — | — | — | — | — | — | — | 1.30K | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | — | — | 1.58M | — | — | 662.00K | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | 149.24K | — | 254.00K | 34.28K | — | — | — | 11.70K | — | — | — | — | — | — | 55.12K |
| Morgan Stanley | — | — | — | — | 66.40K | 79.90K | 50.50K | 102.58K | — | 1.50K | 1.50K | 1.50K | — | — | — | 4 | 4 | — | — | — |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 100.00K | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | 71.10K | — | — | — | — | 18.43K | 54.30K | — | — | — |
| Squarepoint Ops LLC | — | — | — | 17.93K | 95.38K | 49.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Yorkville Advisors Global, LP | — | 78.00K | 78.00K | 100.00K | — | 60.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CANTOR FITZGERALD, L. P. | — | — | — | — | — | — | — | — | 79.49K | — | — | — | — | — | — | — | — | — | — | — |
| MEITAV INVESTMENT HOUSE LTD | — | — | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | 50.00K | 95.00K | 95.00K | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | — | — | 28.67K | — | — | 28.69K | — | 64.64K | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | — | 10.52K | — | — | — | 21.69K | — | 64.39K | — | — | — | 14.00K | — | — | — | — | — | — | — | — |
| Independent Advisor Alliance | — | 100.00K | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| XTX Topco Ltd | — | 11.47K | — | — | — | — | 33.71K | 41.90K | 46.00K | 32.65K | — | — | — | — | — | — | — | — | — | — |
| COMMONWEALTH EQUITY SERVICES, LLC | — | 22.77K | 22.77K | 22.77K | 21.08K | 21.08K | 17.25K | 16.25K | 12.62K | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | — | — | 44.45K | 51.55K | 21.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NRSN?
As of 2026-Q2, 13 institutional funds reported holding NRSN (NEUROSENSE THERAPEUTICS LTD) in SEC 13F filings, with a combined reported value of $297.18K.
How many shares of NRSN do institutions own?
13F filers reported 413.48K shares of NRSN, worth $297.18K in aggregate at the end of 2026-Q2.
Is institutional ownership of NRSN rising or falling?
Share counts moved +40.9% versus the prior quarter — accumulation.
Who are the top institutional holders of NRSN?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Citadel Advisors, Citigroup Inc, Point72 Asset Management, Renaissance Technologies; the top 25 are ranked at the top of this page.
Who are the major shareholders of NEUROSENSE THERAPEUTICS LTD?
The major shareholders of NEUROSENSE THERAPEUTICS LTD (NRSN) by reported 13F value are ARMISTICE CAPITAL, LLC, Citadel Advisors, Citigroup Inc, Point72 Asset Management, Renaissance Technologies, among 40 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.